Government addressing issue misleading advertisements on AYUSH Products: Naik Ruby Khatun Khatun5 Jan 2018 10:30 AM ISTReplying to a question in Rajya Sabha, the Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik said the government is taking...
Infosys partners ValGenesis to enhance digitisation in life sciences Ruby Khatun Khatun5 Jan 2018 10:15 AM ISTLONDON: Infosys announced a new partnership with paperless validation company ValGenesis, that will bring even stronger compliance and quality...
Philippines fines Sanofi, suspends clearance for Dengvaxia Ruby Khatun Khatun5 Jan 2018 10:00 AM ISTMANILA: The Philippines has suspended clearance for Sanofi's dengue vaccine Dengvaxia and fined the French drugmaker a symbolic $2,000 citing...
CMS to cover Abbott's glucose monitoring device Ruby Khatun Khatun5 Jan 2018 9:45 AM ISTAbbott Laboratories said its newly launched glucose monitoring device would be covered by the Centers for Medicare and Medicaid Services (CMS),...
Dr Reddy's drops 4 percent as Duvvada facility receives EIR Ruby Khatun Khatun4 Jan 2018 11:08 AM ISTNew Delhi: Shares of Dr Reddy's Laboratories fell over 4 percent in Wednesday's trade amid reports that an establishment inspection report (EIR) has...
Hetero launches biosimilar Adalimumab in India Ruby Khatun Khatun4 Jan 2018 10:45 AM ISTNew Delhi: Drug firm Hetero said it has launched its biosimilar Adalimumab, used for the treatment of rheumatoid arthritis and other auto-immune...
Spark to charge 850,000 dollars per patient for blindness gene therapy Ruby Khatun Khatun4 Jan 2018 10:30 AM ISTSpark Therapeutics Inc said it will charge $850,000 per patient for its breakthrough gene therapy to treat a rare form of blindness, a lower than the...
Novartis breast cancer therapy gets FDA breakthrough designation Ruby Khatun Khatun4 Jan 2018 10:00 AM ISTZURICH: Novartis’s Kisqali (ribociclib) has won U.S. Food and Drug Administration breakthrough therapy designation for treating some breast cancer...
Momenta, Mylan plan trial of biosimilar to Regeneron eye drug Ruby Khatun Khatun4 Jan 2018 9:30 AM ISTMomenta Pharmaceuticals Inc and Mylan NV plan to begin a pivotal clinical trial of a biosimilar to Regeneron Pharmaceuticals Inc’s blockbuster eye...
Elite Pharmaceuticals gets FDA approval for Phendimetrazine Tartrate tablets Ruby Khatun Khatun3 Jan 2018 10:05 AM ISTNORTHVALE: Elite Pharmaceuticals announced that it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food...
New drug approvals in 2017 hits 21 year high Ruby Khatun Khatun3 Jan 2018 9:45 AM ISTLONDON: U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light more than double the previous year while the...
Drugmakers raise prices in US within self-imposed limits Ruby Khatun Khatun3 Jan 2018 9:30 AM ISTNEW YORK: Drugmakers opened the new year by raising U.S. prices on dozens of medicines, but early data showed the increases generally remained within...
